The big news today is that Apple is reportedly secretly developing a dermal sensor for measuring blood glucose and the management of diabetes. From data acquisition to durability (a one week batter life) that Google innovation might also drive the shift for wearables from an 'athletic option' to 'clinical imperative'. But what really strikes me is the source of innovation and how it seems to come from 'expectedly unexpected' sources like Google and Apple. We're beyond the days when we're shocked that a life science innovation doesn't come from big pharma. Yet and interestingly, when a Google or Amazon or Apple enter the market with a 'significant' innovation, the reaction is more a nod in acknowledgment than a significant surprise.

Source: Forbes April 15, 2017 16:07 UTC